Eli Lilly (LLY) Shares Outstanding (2009 - 2026)

Eli Lilly has reported Shares Outstanding for 18 years, with the latest figure at $943.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.49% year-over-year to $943.5 million; the trailing twelve-month figure through Mar 2026 stood at $943.5 million (changed 0.49% YoY), and the FY2025 full-year result was $944.8 million, changed 0.33% from the prior year.
• Shares Outstanding for Q1 2026 stood at $943.5 million, roughly flat from $944.8 million in the prior quarter.
• The five-year high for Shares Outstanding was $950.8 million in Q2 2024, with the low at $943.5 million in Q1 2026.
• Historically, Shares Outstanding has averaged $948.9 million across 5 years, with a median of $949.7 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding declined 0.93% — and 2024, when it increased 0.12%.
• Eli Lilly's Shares Outstanding stood at $950.6 million in 2022, then decreased by 0.08% to $949.8 million in 2023, then decreased by 0.2% to $947.9 million in 2024, then fell by 0.33% to $944.8 million in 2025, then dropped by 0.14% to $943.5 million in 2026.
• The last three Shares Outstanding figures came in at $943.5 million (Q1 2026), $944.8 million (Q4 2025), and $946.2 million (Q3 2025), per Business Quant data.